An Act to prohibit cost sharing for opioid antagonists
This bill requires various health insurance plans in Massachusetts to cover opioid antagonists, such as naloxone, without charging patients any copay or coinsurance. It directly affects state employees, Medicaid participants, and individuals with private insurance policies issued within the state. The law allows these drugs to be covered under statewide standing orders, meaning a prescription from a doctor is not needed to receive the medication. The only exception to the no-cost rule is for plans governed by federal tax laws that would lose their tax-exempt status if they eliminated cost-sharing for this service.
Bill status
passed
3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023
Last action May 9, 2024
Floor votes
How they voted
This bill passed the House. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
5
Key actions
1
Committee
2
Mar 11, 2024
Senate · Reported by committee
Bill reported favorably by committee and referred to the committee on Health Care Financing
Feb 16, 2023
House · Passed
House concurred
Feb 16, 2023
Senate · Referred to committee
Referred to the committee on Financial Services
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Jason Lewis
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 667
Scope: MA
Hi! I can help you understand S 667. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline